Slashdot Mirror


Genomics Impact On US Economy Approaches $1 Trillion

sciencehabit writes "Despite a slow economy, business in genomics has boomed and has directly and indirectly boosted the U.S. economy by $965 billion since 1988, according to a new study (pdf). In 2012 alone, genomics-related research and development, along with relevant industry activities, contributed $31 billion to the U.S. gross national product and helped support 152,000 jobs, the biomedical funding advocacy group United for Medical Research announced today in Washington, D.C. Based on total U.S. spending, the country gets $65 back for every $1 it spends on the field."

16 of 115 comments (clear)

  1. umm... by bananaquackmoo · · Score: 2, Insightful

    So in other words this stuff really is overpriced?

    1. Re:umm... by rtb61 · · Score: 2, Insightful

      The real questions are out of whose pocket does that $65 come from and into whose pocket is it going and of course how many people are dying because it is priced beyond their reach.

      --
      Chaos - everything, everywhere, everywhen
  2. Wow! by Etherwalk · · Score: 2, Insightful

    Industry Group claims it is useful in own report, film at eleven.

  3. Re:This is FUD by Samantha+Wright · · Score: 4, Insightful

    No, it's more like "please don't stop funding science, specifically this one part."

    --
    Bio questions? Ask me to start a Q&A journal. Computer analogies available for most topics!
  4. of course... by stenvar · · Score: 4, Insightful

    I think public funding of basic research is one of the few areas where the federal government is justified in spending significant amounts of money.

    But "generating economic impact" is a useless measure; the federal government could create a trillion dollars of economic impact by forcing everybody to burn down their houses or by simply forcing everybody to pay twice as much for their health care (well, they are trying the latter), but we wouldn't be better off as a result.

    1. Re:of course... by GodfatherofSoul · · Score: 2, Insightful

      I was with you until the Obamacare crack. Healthcare costs have been skyrocketing for 30 years, now if anyone's premium goes up a dollar that's because of Obamacare? Costs aren't going down, but at least the rate they're growing has started slowing down.

      --
      I swear to God...I swear to God! That is NOT how you treat your human!
    2. Re:of course... by ebno-10db · · Score: 2

      Healthcare costs have been skyrocketing for 30 years, now if anyone's premium goes up a dollar that's because of Obamacare?

      No, but Obamacare does amazingly little to control costs. Obama started by giving pharma and med insurance companies what they wanted. There's a reason why the insurance stocks went up after it passed - what company has a problem with guaranteed customers? A public option would have given them a run for their money, and with pharma the collective bargaining power of 308M people could do something about prices. Some of the cost containment claimed is absurd. It limits the medical loss ratio, to a lower ratio (more for the insurance companies) than what they have now! And the pre-Obamacare MLR is lower than what they had ten years ago. I've believed in universal health care for decades, but I'm not sure we can afford Obama and congress kissing corporate butt like this.

  5. Re:This is FUD by Samantha+Wright · · Score: 4, Insightful

    This is about the human genome, you goof, not crops. The money is from medical innovations. RTFA!

    --
    Bio questions? Ask me to start a Q&A journal. Computer analogies available for most topics!
  6. This is biomedical, not agricultural by ranton · · Score: 3, Informative

    This has nothing to do with Monsanto. This is about medical research that has been boosted by advances such as mapping the human genome.

    --
    -- All that is necessary for the triumph of evil is that good men do nothing. -- Edmund Burke
  7. Cunundrum by EzInKy · · Score: 2

    Quite a cunundrum, isn't it? Most everyone wants to see science advance, most everyone wants everyone to benefit from those scientific advances. How best to do this by encouraging both research and sharing? Still not sure a 20yr monopoly is the best method, but so far have seen very few viable alternatives presented that serve both the benefactors and benefactees.

    --
    Time is what keeps everything from happening all at once.
  8. Re:This is FUD by Mitchell314 · · Score: 4, Insightful

    Besides better understanding of ourselves, vastly improved drugs, methods to understand and predict inherited diseases, risk factor management, and more effective treatments, what has genomics done for us?

    --
    I read TFA and all I got was this lousy cookie
  9. Re:That is the worst story tag I've seen in a whil by Mitchell314 · · Score: 2

    Obviously genomics is the study of gnome genealogies. Come one people, this is basic english. :P

    --
    I read TFA and all I got was this lousy cookie
  10. Re:That is the worst story tag I've seen in a whil by damn_registrars · · Score: 2

    Obviously genomics is the study of gnome genealogies

    Yes, I'm quite sure that is what ... oh, what was that pesky search engine called ... told me. Damnit infoseek!

    --
    Damn_registrars has no butt-hole. Damn_registrars has no use for a butt-hole.
  11. Re:This is FUD by Samantha+Wright · · Score: 3, Insightful

    Woah, woah, what?

    Except that my first take on this was what innovations.

    Every single drug and test invented in the past twelve years has been absolutely dependent on understanding the sequence of the human genome and how its components play together. 15 new anti-cancer drugs were approved in 2012 alone, the most bountiful year for FDA approvals since 1995.

    Yes, a lot of stuff is hyped up, but I've seen precious little utility for genomics in the trenches.

    Then you've never heard of this? Or this? How much more trench-y do you need?

    I think this study is total BS - especially since the methodology is hidden.

    The third page links to the full report, noting that it includes the full methodology behind the study. The word "methodology" is right there in bright blue.

    Sequencing the human genome is interesting, but the real key is sequencing other genomes and comparing them. That's happening with abandon now.

    As far as human health is concerned, the primary questions are (a) how do we work? (b) how do the things that interact with us work? and (c) how does our environment affect us? While many model organisms provide excellent snapshots of simpler genomes that we can use to unravel complex mechanisms (like cell division in yeast), comparative genomics really only teaches us about evolution. It's not relevant to medicine, outside of predicting the evolution of pathogens. We're not benefiting human medicine by sequencing, say, red pandas or sea turtles, although these things are certainly important for other reasons. There are occasionally exceptional genomes, like the naked mole rat (immune to cancer), but these are rare.

    And we're finally getting a handle on what controls the genome and how all the little pieces fit together.

    The biggest recent contributor to that has been ENCODE, which, again, was a direct analysis of human data and did not involve any other species.

    That should yield some better therapies but aside from a few edge cases in cancer treatment, there isn't much out there. And it's not like these cancer treatments have overwhelmingly improved survival - improvements of 20 - 50% are typical. Nothing to sneeze at, but not the Holy Grail.

    We picked all the low-hanging fruit like phenylketonuria as soon as it became technologically feasible. Problems like cancer and severe autism are extremely complex, and the only hope we have to tackle them is through an extremely intimate understandinf of the human genome.

    --
    Bio questions? Ask me to start a Q&A journal. Computer analogies available for most topics!
  12. Re:Where are the jobs? by Mitchell314 · · Score: 2

    Just back of the envelope mental math, but at $60,000 per worker (factoring benefits, training, travel, etc), that's roughly $9 billion, which doesn't seem terribly off. Add double that for supplies and equipment the workers come in contact with, so 9 + 18 = 27, which is in the same ballpark as the $31 billion. An immediate red flag suggesting BS is when you're around 50% or more away, ie the dollar number is near or greater than $40 billion or the job number is near less than ~100,000.

    The medical/chemical field is a hot field with a lot of high salary jobs. A different industry will have different numbers.

    --
    I read TFA and all I got was this lousy cookie
  13. Re:This is FUD by Doubting+Sapien · · Score: 2

    Oh well. I'm trying to talk to the wrong crowed here. Let me find another soap box somewhere else.

    Instead of getting on another soap box and saying anything at all, would you consider stopping to listen to what others are saying? There are many insights being expressed here that are worth thinking about and learning from. If you do have to say something, consider asking an engaging question.

    --
    ========== "Hello World" in my programming language of choice: ATG - LET THERE BE LIFE - TAG ==========